Role of Enteral Probiotics for Prevention of Neonatal Necrotizing Enterocolitis in Preterm Infants: A Randomized Placebo Controlled Trial

Role of Enteral Probiotics for Prevention of Neonatal Necrotizing Enterocolitis in Preterm Infants: A Randomized Placebo Controlled Trial

Authors

  • Muhammad Kalim Akhter King Edward Medical University/Mayo Hospital, Lahore
  • Misbah Noor King Edward Medical University/Mayo Hospital, Lahore
  • Gada Hussain King Edward Medical University/Mayo Hospital, Lahore
  • Tausif Ahmed Akhtar Saeed Medical & Dental College, Lahore 
  • Saba Irshad Lady Aitchison Hospital, Lahore 
  • Akmal Laeeq Chishti King Edward Medical University/Mayo Hospital, Lahore

DOI:

https://doi.org/10.21649/akemu.v25i3.3047

Keywords:

Necrotizing enterocolitis, probiotics, placebo, premature birth, neonates

Abstract

Background: Necrotizing enterocolitis (NEC) is neonatal disease mostly occur in premature neonates, in which the parts of intestine get necrosis. Healthy probiotic agent may be given that can help to resist the condition. These are thought to be non‐pathogenic & non‐invasive, modify immune responses, do not develop resistance to antibiotics and develop from human microflora.

Objective: To compare the frequency of Neonatal necrotizing enterocolitis (NEC) with enteral probiotics versus placebo in preterm infants.

Methods: This randomized controlled trial was conducted at Department of Pediatrics, Mayo Hospital, Lahore for 6months. Total 220 cases were recruited via Non-probability consecutive sampling. Neonates were divided in two groups. One group (control)  received milk (Breast or Formula) and second group (intervention)  received probiotics Lactobacillus GG 3 billion units once daily with the milk for a week. Neonates were observed for NEC signs within 7days.

Results: The mean gestational age of neonates was 32.19±2.90 weeks. There were 133 (60.2%) males and 88 (39.8%) females. The mean weight of neonates was 1581.97±472.60grams. NEC was developed in 10 (9.1%) neonates with placebo while in 7 (6.4%) neonates received probiotics (p-value>0.05).

Conclusion: Our study did not support ben­efit of probiotics for prevention of NEC.

Author Biographies

Muhammad Kalim Akhter, King Edward Medical University/Mayo Hospital, Lahore

Assisstant Professor of Pediatrics Medicine Unit I,

King Edward Medical University/Mayo Hospital, Lahore

Misbah Noor, King Edward Medical University/Mayo Hospital, Lahore

Assisstant Professor of Pediatrics Medicine Unit I,

King Edward Medical University/Mayo Hospital, Lahore

Gada Hussain, King Edward Medical University/Mayo Hospital, Lahore

PGR,

Pediatrics Medicine Unit I,

King Edward Medical University/Mayo Hospital, Lahore

Tausif Ahmed, Akhtar Saeed Medical & Dental College, Lahore 

Assisstant Professor,

Pediatrics Medicine,

Akhtar Saeed Medical & Dental College, Lahore 

Saba Irshad, Lady Aitchison Hospital, Lahore 

Women Medical Officer,

Neonatology,

Lady Aitchison Hospital, Lahore 

Akmal Laeeq Chishti, King Edward Medical University/Mayo Hospital, Lahore

Former Professor & Head of Pediatrics Medicine,

King Edward Medical University/Mayo Hospital, Lahore

Downloads

Published

10/12/2019

How to Cite

Akhter, M. K., Noor, M. ., Hussain, G., Ahmed, T., Irshad, S., & Chishti, A. L. (2019). Role of Enteral Probiotics for Prevention of Neonatal Necrotizing Enterocolitis in Preterm Infants: A Randomized Placebo Controlled Trial. Annals of King Edward Medical University, 25(3). https://doi.org/10.21649/akemu.v25i3.3047

Issue

Section

Research Articles

Most read articles by the same author(s)

Similar Articles

> >> 

You may also start an advanced similarity search for this article.

Loading...